ZBTB24 Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 Genetic Test
Genetic testing plays a crucial role in diagnosing and understanding rare genetic disorders. One such disorder is Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 (ICF2), which is associated with the ZBTB24 gene. At DNA Labs UAE, we offer a comprehensive genetic test for ICF2, providing valuable insights into the condition.
Test Name: ZBTB24 Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 Genetic Test
- Components: ZBTB24 gene analysis
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Osteology Dermatology Immunology Disorders
- Doctor: Dermatologist
- Test Department: Genetics
Pre Test Information
Prior to undergoing the ZBTB24 Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected by the syndrome. This information will aid in the interpretation of the test results and provide a comprehensive understanding of the genetic factors involved.
Test Details
The ZBTB24 gene is associated with Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 (ICF2). This rare genetic disorder is characterized by a weakened immune system, abnormalities in chromosome structure (centromeric instability), and facial anomalies. Our NGS genetic testing utilizes advanced sequencing technology to analyze the DNA sequence of the ZBTB24 gene.
By identifying mutations or variants in the ZBTB24 gene, the NGS genetic test can aid in the diagnosis of ICF2. This information is invaluable for genetic counseling, guiding treatment decisions, and understanding the underlying genetic causes of the syndrome.
At DNA Labs UAE, we are committed to providing accurate and comprehensive genetic testing services. Our ZBTB24 Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 Genetic Test can provide valuable insights into the condition, leading to improved diagnosis and patient care.
| Test Name | ZBTB24 Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ZBTB24 Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ZBTB24 Gene Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 NGS Genetic DNA Test gene ZBTB24 |
| Test Details |
The ZBTB24 gene is associated with a rare genetic disorder called Immunodeficiency-centromeric instability-facial anomalies syndrome type 2 (ICF2). This syndrome is characterized by a weakened immune system, specifically affecting the production of antibodies, as well as centromeric instability (abnormalities in the structure of chromosomes) and facial anomalies. NGS (Next-Generation Sequencing) genetic testing refers to a high-throughput sequencing technology that allows for the analysis of multiple genes simultaneously. In the context of ICF2, NGS genetic testing can be used to identify mutations or variants in the ZBTB24 gene that may be responsible for the syndrome. By analyzing the DNA sequence of the ZBTB24 gene, NGS genetic testing can provide valuable information about the presence of any genetic alterations that may be causing the symptoms of ICF2. This information can be used for diagnosis, genetic counseling, and potentially for guiding treatment decisions. |
